News: #LungCancer treatment compromised by delayed #GenomicTesting results
#UK
Report by @uklungcancer.bsky.social
#UK
Report by @uklungcancer.bsky.social
www.thelancet.com
March 14, 2025 at 1:14 PM
News: #LungCancer treatment compromised by delayed #GenomicTesting results
#UK
Report by @uklungcancer.bsky.social
#UK
Report by @uklungcancer.bsky.social
Great opening plenary by @andrewmallett8.bsky.social at #INSPIRD workshop on the lpioneering work from him and his team on integrating #GenomicTesting for #RenalDisease
#QueenslandHealth
#OfficeOfResearchInnovation
#JamesCookUniversity
#QueenslandHealth
#OfficeOfResearchInnovation
#JamesCookUniversity
May 28, 2025 at 11:33 PM
Great opening plenary by @andrewmallett8.bsky.social at #INSPIRD workshop on the lpioneering work from him and his team on integrating #GenomicTesting for #RenalDisease
#QueenslandHealth
#OfficeOfResearchInnovation
#JamesCookUniversity
#QueenslandHealth
#OfficeOfResearchInnovation
#JamesCookUniversity
A new interactive online tool developed by Australian Genomics provides easy and accessible information in bite-sized chunks to guide patients through the key concepts of genomic testing.
Learn more: www.australiangenomics.org.au/new-online-c...
#genomics #genomictesting #consent #onlinetool
Learn more: www.australiangenomics.org.au/new-online-c...
#genomics #genomictesting #consent #onlinetool
New online consent tool for patients — Australian Genomics
Informed consent is a critical component of genomic and genetic testing. It is a process whereby a patient agrees to undergo genomic testing in full knowledge of the potential risks, benefits and outc...
www.australiangenomics.org.au
January 23, 2025 at 4:38 AM
A new interactive online tool developed by Australian Genomics provides easy and accessible information in bite-sized chunks to guide patients through the key concepts of genomic testing.
Learn more: www.australiangenomics.org.au/new-online-c...
#genomics #genomictesting #consent #onlinetool
Learn more: www.australiangenomics.org.au/new-online-c...
#genomics #genomictesting #consent #onlinetool
#Parents in the #NICU view #genomic testing through a “problem‑solving” lens, using results to navigate #treatment, coping, parenting, and prognosis. This commentary connects the framework to existing models and highlights future research needs. #genomictesting
Read More Here: buff.ly/fHA8JYD
Read More Here: buff.ly/fHA8JYD
January 28, 2026 at 8:01 PM
#Parents in the #NICU view #genomic testing through a “problem‑solving” lens, using results to navigate #treatment, coping, parenting, and prognosis. This commentary connects the framework to existing models and highlights future research needs. #genomictesting
Read More Here: buff.ly/fHA8JYD
Read More Here: buff.ly/fHA8JYD
Many adoptees cite lack of #familyhealth history as their top reason for getting elective #genomictesting. Over 80% saw this as very important — highlighting the unique value of genomics for those with limited family information. #Genomics #PrecisionMedicine
Read Here: buff.ly/4VF8zo8
Read Here: buff.ly/4VF8zo8
December 1, 2025 at 3:20 PM
Many adoptees cite lack of #familyhealth history as their top reason for getting elective #genomictesting. Over 80% saw this as very important — highlighting the unique value of genomics for those with limited family information. #Genomics #PrecisionMedicine
Read Here: buff.ly/4VF8zo8
Read Here: buff.ly/4VF8zo8
Less than two-thirds (60%) of genomic tests in England are delivered on time, according to a recent review.
Help us achieve faster #GenomicTesting and save more lives from #LungCancer.
Read our report ▶️ ow.ly/IFc450V9wGk
Help us achieve faster #GenomicTesting and save more lives from #LungCancer.
Read our report ▶️ ow.ly/IFc450V9wGk
March 7, 2025 at 9:51 AM
Less than two-thirds (60%) of genomic tests in England are delivered on time, according to a recent review.
Help us achieve faster #GenomicTesting and save more lives from #LungCancer.
Read our report ▶️ ow.ly/IFc450V9wGk
Help us achieve faster #GenomicTesting and save more lives from #LungCancer.
Read our report ▶️ ow.ly/IFc450V9wGk
We’re back TOMORROW!
Join #MidwiferyHour Series 16, Ep1 as we explore how midwives can make genomic testing conversations clear & supportive.
🗓 30 April | 🕖 19:00 UK | 🎧 Spotify
Register free: shorturl.at/fcts1
#GenomicTesting #MATFLIX
Join #MidwiferyHour Series 16, Ep1 as we explore how midwives can make genomic testing conversations clear & supportive.
🗓 30 April | 🕖 19:00 UK | 🎧 Spotify
Register free: shorturl.at/fcts1
#GenomicTesting #MATFLIX
April 29, 2025 at 2:01 PM
We’re back TOMORROW!
Join #MidwiferyHour Series 16, Ep1 as we explore how midwives can make genomic testing conversations clear & supportive.
🗓 30 April | 🕖 19:00 UK | 🎧 Spotify
Register free: shorturl.at/fcts1
#GenomicTesting #MATFLIX
Join #MidwiferyHour Series 16, Ep1 as we explore how midwives can make genomic testing conversations clear & supportive.
🗓 30 April | 🕖 19:00 UK | 🎧 Spotify
Register free: shorturl.at/fcts1
#GenomicTesting #MATFLIX
Accurate diagnosis is critical for #RareDisease treatment and prognosis, but the journey is often long and complex. Advances in #GenomicTesting offer hope!
👨⚕️ CLINICIANS: Learn how you can improve diagnostic rates: education.clinical.jax.org/page/exome-t...
#RareDiseaseDay #GeneChat
👨⚕️ CLINICIANS: Learn how you can improve diagnostic rates: education.clinical.jax.org/page/exome-t...
#RareDiseaseDay #GeneChat
February 28, 2025 at 3:04 PM
Accurate diagnosis is critical for #RareDisease treatment and prognosis, but the journey is often long and complex. Advances in #GenomicTesting offer hope!
👨⚕️ CLINICIANS: Learn how you can improve diagnostic rates: education.clinical.jax.org/page/exome-t...
#RareDiseaseDay #GeneChat
👨⚕️ CLINICIANS: Learn how you can improve diagnostic rates: education.clinical.jax.org/page/exome-t...
#RareDiseaseDay #GeneChat
Thousands of UK #LungCancer patients could be missing out on life-extending targeting treatments due to delays in #GenomicTesting turnaround times. ⏰
Read how we can speed up the testing process here ▶️ ow.ly/fO3050V9wE0
#NHS #PatientCare #BTOG25
Read how we can speed up the testing process here ▶️ ow.ly/fO3050V9wE0
#NHS #PatientCare #BTOG25
March 5, 2025 at 9:42 AM
Thousands of UK #LungCancer patients could be missing out on life-extending targeting treatments due to delays in #GenomicTesting turnaround times. ⏰
Read how we can speed up the testing process here ▶️ ow.ly/fO3050V9wE0
#NHS #PatientCare #BTOG25
Read how we can speed up the testing process here ▶️ ow.ly/fO3050V9wE0
#NHS #PatientCare #BTOG25
🦓 DYK 1 in 10 Americans have a #RareDisease?
#GenomicTesting can play a role in determining next steps for a potential diagnosis. #MedSky
This new case-based module lets providers practice communicating with patients & consult with genetic experts: education.clinical.jax.org/page/exome-t...
#GenomicTesting can play a role in determining next steps for a potential diagnosis. #MedSky
This new case-based module lets providers practice communicating with patients & consult with genetic experts: education.clinical.jax.org/page/exome-t...
Genomic Testing for Diagnosis
Free CME and CNE modules on genomic testing
education.clinical.jax.org
May 15, 2025 at 11:36 AM
🦓 DYK 1 in 10 Americans have a #RareDisease?
#GenomicTesting can play a role in determining next steps for a potential diagnosis. #MedSky
This new case-based module lets providers practice communicating with patients & consult with genetic experts: education.clinical.jax.org/page/exome-t...
#GenomicTesting can play a role in determining next steps for a potential diagnosis. #MedSky
This new case-based module lets providers practice communicating with patients & consult with genetic experts: education.clinical.jax.org/page/exome-t...
Genomic profiling helps assess melanoma risk by analyzing microRNA expressions in lesions. Researchers create a scoring system for malignancy by identifying microRNA signatures, aiming to standardize diagnostics. #MelanomaAwareness #GenomicTesting #SkinHealth
July 16, 2025 at 11:02 PM
Genomic profiling helps assess melanoma risk by analyzing microRNA expressions in lesions. Researchers create a scoring system for malignancy by identifying microRNA signatures, aiming to standardize diagnostics. #MelanomaAwareness #GenomicTesting #SkinHealth
Not all samples tell the same story. New data from the #TAXIS study show genomic tests on lymph nodes may misclassify breast cancer risk in 1 out of 6 cases. Primary tumour remains the gold standard.
#BreastCancer #GenomicTesting #TAXISstudy #ClinicalResearch
#BreastCancer #GenomicTesting #TAXISstudy #ClinicalResearch
New findings from TAXIS study | Department of Clinical Research | University of Basel
Sub-study: Genomic tests are more reliable from primary tumour tissue than from lymph nodes.
dkf.unibas.ch
July 15, 2025 at 8:44 AM
Not all samples tell the same story. New data from the #TAXIS study show genomic tests on lymph nodes may misclassify breast cancer risk in 1 out of 6 cases. Primary tumour remains the gold standard.
#BreastCancer #GenomicTesting #TAXISstudy #ClinicalResearch
#BreastCancer #GenomicTesting #TAXISstudy #ClinicalResearch
Genetic markers in moles unveil melanoma insights. Small molecules show severity; genomic tech detects RNA shifts, aiding early cancer detection. Result? Greater accuracy in diagnosis with 'molecular profiles.' #MelanomaAwareness #GenomicTesting #SkinHealth #NextGenMedicine
July 13, 2025 at 11:42 PM
Genetic markers in moles unveil melanoma insights. Small molecules show severity; genomic tech detects RNA shifts, aiding early cancer detection. Result? Greater accuracy in diagnosis with 'molecular profiles.' #MelanomaAwareness #GenomicTesting #SkinHealth #NextGenMedicine
Our accreditations reflect our commitment to delivering reliable, high-quality genetic testing services to our valued customers. We are proud to continuously uphold the highest levels of quality and compliance!
#genetictesting #genetics #genomictesting #genomics #genetictests
#genetictesting #genetics #genomictesting #genomics #genetictests
August 6, 2026 at 9:41 AM
Our accreditations reflect our commitment to delivering reliable, high-quality genetic testing services to our valued customers. We are proud to continuously uphold the highest levels of quality and compliance!
#genetictesting #genetics #genomictesting #genomics #genetictests
#genetictesting #genetics #genomictesting #genomics #genetictests
Our new report ‘Faster Testing, Better Outcomes – #GenomicTesting in #LungCancer’ offers practical solutions for timely, accurate, and high-quality genomic test results across the UK.
Read the report ▶️ ow.ly/unCP50V9wFC
Read the report ▶️ ow.ly/unCP50V9wFC
March 11, 2025 at 9:35 AM
Our new report ‘Faster Testing, Better Outcomes – #GenomicTesting in #LungCancer’ offers practical solutions for timely, accurate, and high-quality genomic test results across the UK.
Read the report ▶️ ow.ly/unCP50V9wFC
Read the report ▶️ ow.ly/unCP50V9wFC
MicroRNAs influence gene activity and their disruption in melanoma aids cancer growth. This forms a molecular fingerprint separating melanoma from benign moles. Tracking these changes can enable earlier, precise diagnoses. #MelanomaAwareness #GenomicTesting #SkinHealth #NextGenMedicine
July 14, 2025 at 11:06 PM
MicroRNAs influence gene activity and their disruption in melanoma aids cancer growth. This forms a molecular fingerprint separating melanoma from benign moles. Tracking these changes can enable earlier, precise diagnoses. #MelanomaAwareness #GenomicTesting #SkinHealth #NextGenMedicine
Curious to learn more about Genseq and what we do? At Genseq, we combine scientific expertise, advanced technology and a commitment to quality to provide genomic testing solutions that meet the needs of our partners.
#genomictesting #genetictesting #genetictestingireland
#genomictesting #genetictesting #genetictestingireland
July 29, 2026 at 1:57 PM
Curious to learn more about Genseq and what we do? At Genseq, we combine scientific expertise, advanced technology and a commitment to quality to provide genomic testing solutions that meet the needs of our partners.
#genomictesting #genetictesting #genetictestingireland
#genomictesting #genetictesting #genetictestingireland
Less than two-thirds (60%) of genomic tests in England are delivered on time, according to a recent review.
Help us achieve faster #GenomicTesting and save more lives from #LungCancer.
Read our report ow.ly/IFc450V9wGk
Help us achieve faster #GenomicTesting and save more lives from #LungCancer.
Read our report ow.ly/IFc450V9wGk
April 11, 2025 at 12:02 PM
Less than two-thirds (60%) of genomic tests in England are delivered on time, according to a recent review.
Help us achieve faster #GenomicTesting and save more lives from #LungCancer.
Read our report ow.ly/IFc450V9wGk
Help us achieve faster #GenomicTesting and save more lives from #LungCancer.
Read our report ow.ly/IFc450V9wGk
Tonight at 7PM!
#MidwiferyHour is back with Series 16, Ep1 — we're talking genomic testing at the first midwifery appointment.
Join Jo Hargrave, Marianne Quinn & Karen Creed
30th April | 🕖 7PM UK
Register free: shorturl.at/fcts1
#GenomicTesting #MATFLIX
#MidwiferyHour is back with Series 16, Ep1 — we're talking genomic testing at the first midwifery appointment.
Join Jo Hargrave, Marianne Quinn & Karen Creed
30th April | 🕖 7PM UK
Register free: shorturl.at/fcts1
#GenomicTesting #MATFLIX
April 30, 2025 at 3:45 PM
Tonight at 7PM!
#MidwiferyHour is back with Series 16, Ep1 — we're talking genomic testing at the first midwifery appointment.
Join Jo Hargrave, Marianne Quinn & Karen Creed
30th April | 🕖 7PM UK
Register free: shorturl.at/fcts1
#GenomicTesting #MATFLIX
#MidwiferyHour is back with Series 16, Ep1 — we're talking genomic testing at the first midwifery appointment.
Join Jo Hargrave, Marianne Quinn & Karen Creed
30th April | 🕖 7PM UK
Register free: shorturl.at/fcts1
#GenomicTesting #MATFLIX
🚨 Urgent action must be taken to address the ‘unacceptable’ delays in #GenomicTesting turnaround times for #LungCancer patients.
Read our new report on how we can speed up the process and prolong lives ▶️ ow.ly/GquQ50V9wCe
#BTOG25
Read our new report on how we can speed up the process and prolong lives ▶️ ow.ly/GquQ50V9wCe
#BTOG25
March 4, 2025 at 11:02 AM
🚨 Urgent action must be taken to address the ‘unacceptable’ delays in #GenomicTesting turnaround times for #LungCancer patients.
Read our new report on how we can speed up the process and prolong lives ▶️ ow.ly/GquQ50V9wCe
#BTOG25
Read our new report on how we can speed up the process and prolong lives ▶️ ow.ly/GquQ50V9wCe
#BTOG25
#GenomicTesting is critical for #LungCancer diagnosis and treatment, enabling access to innovative, personalised treatments.
Delays in testing can significantly impact survival rates.
Read our report on how we can speed up the #GenomicsTesting pathway▶️ ow.ly/Xu2B50V9wGC
Delays in testing can significantly impact survival rates.
Read our report on how we can speed up the #GenomicsTesting pathway▶️ ow.ly/Xu2B50V9wGC
March 10, 2025 at 1:35 PM
#GenomicTesting is critical for #LungCancer diagnosis and treatment, enabling access to innovative, personalised treatments.
Delays in testing can significantly impact survival rates.
Read our report on how we can speed up the #GenomicsTesting pathway▶️ ow.ly/Xu2B50V9wGC
Delays in testing can significantly impact survival rates.
Read our report on how we can speed up the #GenomicsTesting pathway▶️ ow.ly/Xu2B50V9wGC
🧬 Innovation on chip! China is revolutionizing diagnostics through biochips. 🇨🇳🔍
#Biochips #ChinaBiotech #GenomicTesting #LabOnChip
www.marketresearchfuture.com/reports/chin...
#Biochips #ChinaBiotech #GenomicTesting #LabOnChip
www.marketresearchfuture.com/reports/chin...
China Biochips Market Size, Growth Outlook 2035
China Biochips Market growth is projected to reach 2.5 USD billion, at a 8.687% CAGR by driving size, share, top company analysis, segments research, trends and forecast report 2025 to 2035.
www.marketresearchfuture.com
June 16, 2025 at 5:29 AM
🧬 Innovation on chip! China is revolutionizing diagnostics through biochips. 🇨🇳🔍
#Biochips #ChinaBiotech #GenomicTesting #LabOnChip
www.marketresearchfuture.com/reports/chin...
#Biochips #ChinaBiotech #GenomicTesting #LabOnChip
www.marketresearchfuture.com/reports/chin...
www.genomicseducation.hee.nhs.uk/news/dermato...
Calling all #dermatologists! We've just launched our new #GeNotes collection of resources to support you in accessing #GenomicTesting for your patients. Developed by Dr fellow dermatology experts, this is one not to miss!
Calling all #dermatologists! We've just launched our new #GeNotes collection of resources to support you in accessing #GenomicTesting for your patients. Developed by Dr fellow dermatology experts, this is one not to miss!
Dermatology joins GeNotes as 12th specialty - Genomics Education Programme
New dermatology collection covers a wide range of clinical scenarios, underpinned by extended opportunities for learning Dermatology professionals now have access to a fantastic new set of useful reso...
www.genomicseducation.hee.nhs.uk
September 8, 2025 at 9:48 PM
www.genomicseducation.hee.nhs.uk/news/dermato...
Calling all #dermatologists! We've just launched our new #GeNotes collection of resources to support you in accessing #GenomicTesting for your patients. Developed by Dr fellow dermatology experts, this is one not to miss!
Calling all #dermatologists! We've just launched our new #GeNotes collection of resources to support you in accessing #GenomicTesting for your patients. Developed by Dr fellow dermatology experts, this is one not to miss!
Immunohistochemistry v. Genomic Profiling: Game on for Her2Low. #her2low #genomictesting
Current breast cancer classification methods, particularly immunohistochemistry and PAM50, face challenges in accurately characterizing the HER2-low subtype, ... read more:
www.nature.com/articles/s41...
Current breast cancer classification methods, particularly immunohistochemistry and PAM50, face challenges in accurately characterizing the HER2-low subtype, ... read more:
www.nature.com/articles/s41...
The Breast Cancer Classifier refines molecular breast cancer classification to delineate the HER2-low subtype - npj Breast Cancer
npj Breast Cancer - The Breast Cancer Classifier refines molecular breast cancer classification to delineate the HER2-low subtype
www.nature.com
February 21, 2025 at 1:41 AM
Immunohistochemistry v. Genomic Profiling: Game on for Her2Low. #her2low #genomictesting
Current breast cancer classification methods, particularly immunohistochemistry and PAM50, face challenges in accurately characterizing the HER2-low subtype, ... read more:
www.nature.com/articles/s41...
Current breast cancer classification methods, particularly immunohistochemistry and PAM50, face challenges in accurately characterizing the HER2-low subtype, ... read more:
www.nature.com/articles/s41...
💭 Do physicians have sufficient knowledge about #GenomicMedicine?
As #GenomicTesting becomes an increasingly routine part of clinical care — from #RareDiseases to tailored treatments for diabetes and cardiovascular disease — an important question arises: are physicians sufficiently prepared?
As #GenomicTesting becomes an increasingly routine part of clinical care — from #RareDiseases to tailored treatments for diabetes and cardiovascular disease — an important question arises: are physicians sufficiently prepared?
!["Do phuysicians who are not specialists in clinical genetics have sufficient knowledge to be able to order relevant tests, interpret test results and talk to patients? How do they prefer to work with genomic medicine? What support do they need and how to they want to learn more? [...]" Continue reading on the Ethics Blog! Link in comments!](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:bezmein3nazfuim6yacxeueb/bafkreicpwmt2bippmeg53fajjyiicndddmeoy7llxm7mmsnniq5gq6pmre)
February 6, 2026 at 10:12 AM
💭 Do physicians have sufficient knowledge about #GenomicMedicine?
As #GenomicTesting becomes an increasingly routine part of clinical care — from #RareDiseases to tailored treatments for diabetes and cardiovascular disease — an important question arises: are physicians sufficiently prepared?
As #GenomicTesting becomes an increasingly routine part of clinical care — from #RareDiseases to tailored treatments for diabetes and cardiovascular disease — an important question arises: are physicians sufficiently prepared?